In ESCC patients, CD103+CD8+ TRM cells are enriched in tumor tissues and metastatic lymph nodes, correlating with improved OS, controlled lymphatic invasion, and reduced metastasis. The gene discussed is CD8A; the disease is esophageal squamous cell carcinoma.